Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL1005212

O=S(=O)(O)C(F)(F)F.c1ccc(N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PTPN1 P18031 1/20 0.41
APOBEC3G Q9HC16 1/20 0.40
CRHBP P24387 1/20 0.39
ATM Q13315 1/20 0.39
CRHR2 Q13324 1/20 0.39
TLR9 Q9NR96 1/20 0.39
TSHR P16473 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL1005215 0.83 ALDH1A1 (0.46) ALDH1A1TDP1KDM4EMEN1KMT2A
Biphenyl SCHEMBL1050411 0.79 PTPN1 (0.58) ALDH1A1MAPTCYP2C9MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL30552135 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1TDP1PTPN1TSHR
Trifluoromethanesulfonic Acid SCHEMBL789189 0.78 ALDH1A1 (0.50) ALDH1A1L3MBTL1TDP1PTPN1TSHR
Biphenyl SCHEMBL5410059 0.77 PTPN1 (0.56) ALDH1A1MAPTCYP2C9MEN1KMT2A
Biphenyl SCHEMBL304392 0.77 PTPN1 (0.56) ALDH1A1MAPTCYP2C9MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL9470710 0.77 CA1 (0.52) ALDH1A1L3MBTL1TDP1CYP3A4PTPN1
Trifluoromethanesulfonic Acid SCHEMBL3345470 0.77 CA1 (0.52) ALDH1A1L3MBTL1TDP1CYP3A4PTPN1
Trifluoromethanesulfonic Acid SCHEMBL29657724 0.77 CA1 (0.52) ALDH1A1L3MBTL1TDP1CYP3A4PTPN1
Biphenyl SCHEMBL2192409 0.77 PTPN1 (0.56) ALDH1A1MAPTCYP2C9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805298-B Method for preparing thiolactide 中国科学院长春应用化学研究所 2024-02-09 CN disclosed
CN-107513015-B Method for preparing 3-benzoyl ethyl acrylate from enalapril intermediate synthesis mother liquor 浙江工业大学 2020-11-06 CN disclosed
CN-103333544-B Ultraviolet curing printing ink as well as preparation method and security product thereof PRINTING SCIENCE & TECHNOLOGY INST THE PEOPLES BAN 2014-11-26 CN disclosed
CN-103333544-A Ultraviolet curing printing ink as well as preparation method and security product thereof PRINTING SCIENCE & TECHNOLOGY INST THE PEOPLES BANK CHINA 2013-10-02 CN disclosed
US-20110033716-A1 GAS-BARRIER COMPOSITION, COATING FILM, PROCESS FOR PRODUCING THE SAME, AND LAYERED MATERIAL MITSUI CHEMICALS, INC. (JP) 2011-02-10 US disclosed
US-7879947-B2 Gas-barrier composition, coating film and method for production of the same, and layered material MITSUI CHEMICALS, INC. (JP) 2011-02-01 US disclosed
EP-2277954-A1 GAS BARRIER COMPOSITION, COATING FILM, METHOD FOR PRODUCING THE GAS BARRIER COMPOSITION, METHOD FOR PRODUCING THE COATING FILM, AND MULTILAYER BODY Mitsui Chemicals, Inc. (JP) 2011-01-26 EP disclosed
EP-1731498-B1 METHOD FOR PRODUCING ESTER AND ESTERIFICATION CATALYST INST NAGOYA IND SCIENCE RES (JP) 2010-05-19 EP disclosed
US-20090171003-A1 Gas-barrier composition, coating film and method for production of the same, and layered material MITSUI CHEMICALS, INC. (JP) 2009-07-02 US disclosed
US-7524900-B2 Gas-barrier composition, coating film and method for production of the same, and layered material MITSUI CHEMICALS, INC. (JP) 2009-04-28 US disclosed
US-20090054649-A1 Bridged Organosilane and Production Method Thereof KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-02-26 US disclosed
US-7435527-B2 Mixture of acid generator and resin insoluble in alkaline developer and another acid decomposable compound FUJIFILM CORPORATION (JP) 2008-10-14 US disclosed
EP-1894971-A1 GAS BARRIER COMPOSITION, COATING FILM, METHODS FOR PRODUCING THOSE, AND MULTILAYER BODY Mitsui Chemicals, Inc. (JP) 2008-03-05 EP disclosed
US-20060293448-A1 Gas-barrier composition, coating film and method for production of the same, and layered material MITSUI CHEMICALS, INC. (JP) 2006-12-28 US disclosed
EP-1731498-A1 METHOD FOR PRODUCING ESTER AND ESTERIFICATION CATALYST Nagoya Industrial Science Research Institute (JP) 2006-12-13 EP disclosed
US-20040253538-A1 Positive resist composition FUJI PHOTO FILM CO., LTD. 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054649-A1 Bridged Organosilane and Production Method Thereof C5, CCNE1, QSOX1 ALDH1A1 866/4885L3MBTL1 420/4885TDP1 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.